Frank R. Jimenez - 01 Mar 2024 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
GC & Corporate Secretary
Signature
/s/ Frank R. Jimenez
Issuer symbol
GEHC
Transactions as of
01 Mar 2024
Net transactions value
-$1,030,004
Form type
4
Filing time
05 Mar 2024, 17:51:57 UTC
Previous filing
04 Jan 2024
Next filing
12 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Tax liability $588,117 -6,443 -8.4% $91.28 69,885 01 Mar 2024 Direct F1
transaction GEHC Common Stock, par value $0.01 per share Tax liability $441,886 -4,841 -6.9% $91.28 65,044 01 Mar 2024 Direct F1
transaction GEHC Common Stock, par value $0.01 per share Award $0 +9,437 +15% $0.000000 74,481 01 Mar 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award $0 +26,840 $0.000000 26,840 01 Mar 2024 Common Stock, par value $0.01 per share 26,840 $92.72 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
F2 Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.
F3 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F4 Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.